Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Subviral Agents

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA.

Antiviral chemistry & chemotherapy·2018

Same author

Highlights of the 30th International Conference on Antiviral Research.

Antiviral research·2017

Same author

Meeting report: 29th International Conference on Antiviral Research in La Jolla, CA, USA.

Antiviral research·2016

Same author

Meeting report: 28th International Conference on Antiviral Research in Rome, Italy.

Antiviral research·2015

Same author

AVCC 1990-2015--A journal to combine antiviral biology and antiviral chemistry enters the third era.

Antiviral chemistry & chemotherapy·2015

Same author

Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA.

Antiviral research·2014

Search research articles

Related Experiment Video

Updated: May 12, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Recent developments in anti-herpesvirus drugs.

Hugh J Field¹, R Anthony Vere Hodge

¹Queens' College, Cambridge, UK. hjf10@cam.ac.uk

British Medical Bulletin

|April 19, 2013

Summary

Antiviral drugs like acyclovir and famciclovir effectively treat herpesviruses, but drug resistance and safety concerns persist, especially in immunocompromised patients. New treatments and research avenues are needed to address these challenges.

Area of Science:

Virology
Pharmacology
Infectious Diseases

Background:

Herpesviruses cause lifelong infections, posing treatment challenges.
Current antivirals like acyclovir and famciclovir are effective but have limitations.
Drug resistance and safety are concerns, particularly in immunocompromised individuals.

Purpose of the Study:

To review current antiviral therapies for herpesvirus infections.
To discuss challenges in developing new antiviral drugs.
To explore potential new uses for existing antivirals.

Main Methods:

Literature review of original papers, reviews, and clinical trial data.
Analysis of drug efficacy, safety profiles, and resistance patterns.
Discussion of controversial aspects and future research directions.

More Related Videos

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Related Experiment Videos

Last Updated: May 12, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals

Published on: September 20, 2021

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Main Results:

Acyclovir and famciclovir show good safety and low resistance in healthy populations.
Ganciclovir is the preferred treatment for cytomegalovirus disease.
Drug resistance is more common in immunocompromised patients, necessitating alternative therapies.

Conclusions:

While current antivirals are valuable, improved safety and efficacy are needed, especially for immunocompromised patients.
Further research into novel antiviral compounds and new applications for existing drugs is crucial.
Addressing challenges in drug development is essential to meet the medical need for effective herpesvirus treatments.